A new discovery about how the liver flushes cholesterol from the body could lead to more effective treatments for cardiovascular disease – the leading cause of death worldwide.
Rsearchers developed a novel bioelectronic device that taps into the natural electrical activity of certain bacteria found on our skin, paving the way for a drug-free approach to managing infections.
A ‘mini-protein’ can deliver radiation doses directly to tumours without harming healthy tissues. The approach shows promise for the treatment of metastatic bladder cancer and other tumours.
Cerebral venous sinus thrombosis (CVT) is a type of stroke that typically affects women between 20 and 50. Researchers developed a way to predict which patients are at risk of epilepsy after a CVT.
Alzheimer’s disease may damage the brain in two distinct phases, based on new research funded by the National Institutes of Health (NIH) using sophisticated brain mapping tools.
An “out-of-this-world” project has the potential to transform the future of tissue engineering and liver transplantation through research conducted aboard the International Space Station (ISS).
New research has revealed that the connection between PFAS, and kidney damage may be tied to dysregulation of the gut microbiome.
A European research team has now shown that dietary measures are more effective in IBS patients with defects in carbohydrate digestion genes than in those without these changes.
The study offers valuable insights into the impact of AI technologies on everyday clinical processes. Above all, however, the study calls for clearly structured future research.
How do the three large protein complexes – the ribosome, the SKI complex and the exosome – interact? A team of scientists led by Elena Conti reveals this question in their current study.
A study led by Assistant Professor Masamitsu Sone and Professor Yoshifumi Yamaguchi from Hokkaido University, Japan, has uncovered a crucial gene that enables hibernating Syrian hamsters (Mesocricetus auratus) to prevent cold-induced cell death. The research was published in the journal Cell Death and Disease.
The gut microbiome varies from person to person in terms of the bacterial species represented and their colonization density. Segatella copri is the most prominent germ. Researchers at the Helmholtz Centre for Infection Research goal to clarify its health significance.
The study findings of a team from Julius-Maximilians-Universität Würzburg (JMU) in Bavaria, Germany help to broaden the conceptual view on the DNA damage response and to link it more closely with RNA metabolism.
People who have been fully vaccinated against Covid-19 have a significantly lower risk of developing more severe cardiovascular conditions linked to Covid-19 infection, a new study shows.
Scientists at the University of Geneva (UNIGE) and the Geneva University Hospitals (HUG) have developed CAR-T cells capable of targeting malignant gliomas while preserving healthy tissue.
“Evidence is mounting that pollutants in soil as well as in water may damage cardiovascular health,” find the authors of a new publication, which advocates the need for more sustainability.
A newfound molecule, called ACBI3, could potentially lead to new therapies against hard-to-treat cancers, improving outcomes for all patients with cancers caused by KRAS mutations.
A new study reveals that cardiometabolic risk factors and subclinical atherosclerosis impair the function of the microvessels that irrigate the heart, potentially increasing atherosclerosis risk.
STAb-T, a new form of immunotherapy to treat solid tumours shows therapeutic potential in animal models with non-small cell lung cancer. The new strategy is designed to strengthen the defensive cells.
Researchers identified the genetic background of the previously known but mysterious AnWj blood group antigen. The findings allow identification and treatment of patients lacking this blood group.
The Nutri-Score is designed to provide consumers with information on nutritional quality. New research reveals that the ratings also correspond with the cardiovascular health impact of the products.
Only 20-40% of patients respond positively to immunotherapy, and these rates vary across different types of cancer. Researchers now identified five key factors that determine response and survival.
The microbiome – bacteria in the GI tract – is essential for digesting food and training the immune system. New studies explore how repeated antibiotic use can upset this delicate system.
Currently, it is difficult to predict whether a cancer patient will respond to immunotherapy or not. A new method to quantify the heterogeneity of the tumour microenvironment aims to improve this.
Two international studies presented at the ESMO Congress 2024 show no increase in recurrence or new breast cancers in women who breastfeed after being treated for breast cancer.
